Previous studies indicated that E2F2 was a significantly upregulated transcription factor in ovarian cancer epithelial cells and among the OC samples, and simultaneously, high E2F2 expression was negatively associated with tumor stage and outcome among OC patients (60). Here, E2F2 is linked to ovarian carcinoma.